| Literature DB >> 34849097 |
Gabriela Otília Mendonça1, Maria Luiza Bianchini Severino1, Kelle Moreira DE Oliveira1, Marcelo Lima DE Oliveira1, Giovane Galdino DE Souza1, Adriano Prado Simão1, Daniel Ferreira Moreira Lobato2, Ranielly Alves Andrade3, Ricardo Zenun Franco4, Marcelo Stegmann DA Cruz5, Leonardo César Carvalho1.
Abstract
OBJECTIVE: To analyze the effects of neuromuscular electrical stimulation of the femoral quadriceps associated or not with whey protein supplementation on the electromyographic activity and body mass distribution in volunteers undergoing anterior cruciate ligament reconstruction.Entities:
Keywords: Anterior Cruciate Ligament Reconstruction; Electric Stimulation; Whey Proteins
Year: 2021 PMID: 34849097 PMCID: PMC8601387 DOI: 10.1590/1413-785220212906237983
Source DB: PubMed Journal: Acta Ortop Bras ISSN: 1413-7852 Impact factor: 0.513
Figure 1Distribution of body mass in the anterior, posterior, injured and healthy limbs.
Figure 2Abbreviations: BC, basal control group; WE, whey protein and neuromuscular electrical stimulation (NMES) group. ES, NMES group.
Mean values ± standard deviation of age, body mass, height, body mass index (BMI), time of injury, and type of graft used in the different study groups.
| Variable | BC (n = 7) | WE (n = 8) | ES (n = 7) | P Value | |
|---|---|---|---|---|---|
| Age (years) | 27.71 ± 6.73 | 35.13 ± 8.77 | 32.29 ± 9.14 | 0.487 | |
| Body Mass (kg) | 75.51 ± 4.96 | 85.50 ± 6.65 | 77.36 ± 10.50 | 0.070 | |
| Stature (m) | 1.73 ± 0.05 | 1.79 ± 0.07 | 1.76 ± 0.05 | 0.180 | |
| BMI (kg/m2) | 25.32 ± 2.12 | 26.79 ± 1.41 | 25.18 ± 3.71 | 0.226 | |
| Mean Time of Injury(months) | 10.71 ± 8.69 | 7.25 ± 6.25 | 13.00 ± 16.85 | 0.621 | |
| Type of Graft | GF(%) | 5 (71.42%) | 7 (87.5%) | 6 (85.71%) | 0.686 |
| GP(%) | 2 (28.58%) | 1 (12.5%) | 1 (14.83%) |
Abbreviations: BC, basal control group; WE, whey protein and neuromuscular electrical stimulation (NMES) group; ES, NMES group; GF, graft with flexor tendon; GP, graft with patellar tendon.
Normalized electromyographic analysis of the muscles of the injured knee during the bipodal mini squat with eyes open (EO) and closed (EC) among the different groups of the study in the pre- and postoperative evaluations.
| Variable | Groups | PRE | POST | ANOVA p value | f2 | ||
|---|---|---|---|---|---|---|---|
| Evaluation | Group | Evaluation*Group | |||||
| VM-EO | BC | 45.85 ± 25.32* | 16.37 ± 13.57 | 0.005 | 0.506 | 0.435 | 0.342 |
| WE | 46.32 ± 23.45 | 32.86 ± 20.26 | |||||
| ES | 50.96 ± 39.66 | 32.02 ± 27.10 | |||||
| VL-EO | BC | 52.42 ± 41.20* | 23.30 ± 16.39 | 0.005 | 0.718 | 0.362 | 0.343 |
| WE | 44.19 ± 24.92 | 31.55 ± 19.07 | |||||
| ES | 54.75 ± 30.03 | 35.31 ± 26.78 | |||||
| RF-EO | BC | 55.01 ± 31.68 | 34.64 ± 25.29 | 0.075 | 0.146 | 0.349 | 0.157 |
| WE | 57.39 ± 49.28 | 55.72 ± 47.70 | |||||
| ES | 26.11 ± 16.03 | 18.96 ± 11.76 | |||||
| VM-EC | BC | 44.80 ± 22.65* | 16.37 ± 13.57 | 0.003 | 0.251 | 0.526 | 0.385 |
| WE | 44.82 ± 22.17 | 29.98 ± 21.71 | |||||
| ES | 50.62 ± 38.46 | 33.14 ± 25.96 | |||||
| VL-EC | BC | 45.72 ± 41.43* | 23.53 ± 16.28 | 0.020 | 0.559 | 0.722 | 0.254 |
| WE | 44.72 ± 29.60 | 31.36 ± 19.09 | |||||
| ES | 53.87 ± 30.63 | 35.25 ± 26.82 | |||||
| RF-EC | BC | 55.28 ± 37.60 | 30.49 ± 26.75 | 0.074 | 0.826 | 0.256 | 0.308 |
| WE | 38.90 ± 28.84 | 35.43 ± 20.15 | |||||
| ES | 44.89 ± 33.03 | 21.54 ± 16,92 | |||||
Abbreviations: f2, effect size; VM, vastus medialis muscle; BC, basal control; WE, group that received whey protein in association with neuromuscular electrical stimulation (NMES) in the femoral quadriceps; ES, group that received only NMES in the femoral quadriceps; VL, vastus lateralis muscle; RF, rectus femoris muscle; * versus pre-evaluation, differs significantly based on the Bonferroni test (p < 0.05).
Normalized electromyographic analysis of muscles of the healthy lower limb during the bipodal mini squat with eyes open (EO) and closed (EC) among the different groups of the study in the pre- and postoperative evaluations.
| Variable | Groups | PRE | POST | ANOVA p value | f2 | ||
|---|---|---|---|---|---|---|---|
| Evaluation | Group | Evaluation*Group | |||||
| VM-EO | BC | 34.85 ± 24.34 | 41.15 ± 22.68 | 0.053 | 0.647 | 0.377 | 0.182 |
| WE | 46.97 ± 21.48 | 59.12 ± 40.01 | |||||
| ES | 39.99 ± 26.77 | 56.22 ± 29.47 | |||||
| VL-EO | BC | 38.12 ± 25.00 | 41.98 ± 26.34 | 0.250 | 0.547 | 0.259 | 0.069 |
| WE | 48.26 ± 23.40 | 54.54 ± 24.32 | |||||
| ES | 36.66 ± 26.47 | 53.31 ± 25.62 | |||||
| RF-EO | BC | 48.76 ± 43.49 | 73.53 ± 64.01 | 0.054 | 0.074 | 0.831 | 0.202 |
| WE | 22.44 ± 13.14 | 38.79 ± 25.68 | |||||
| ES | 23.83 ± 13.67 | 30.98 ± 20.63 | |||||
| VM-EC | BC | 34.72 ± 25.81 | 43.55 ± 21.29 | 0.087 | 0.777 | 0.241 | 0.241 |
| WE | 48.28 ± 30.21 | 51.72 ± 35.44 | |||||
| ES | 35.06 ± 31.09 | 54.58 ± 30.04 | |||||
| VL-EC | BC | 42.85 ± 30.90 | 39.47 ± 19.84 | 0.211 | 0.721 | 0.118 | 0.086 |
| WE | 48.11 ± 25.59 | 52.03 ± 25.62 | |||||
| ES | 27.97 ± 19.27 | 54.65 ± 35.04 | |||||
| RF-EC | BC | 29.41 ± 15.24 | 37.43 ± 18.25 | 0.080 | 0.618 | 0.685 | 0.160 |
| WE | 36.62 ± 34.24 | 42.46 ± 31.11 | |||||
| ES | 28.81 ± 15.51 | 46.97 ± 35.95 | |||||
Abbreviations: f2, effect size; VM, vastus medialis muscle; BC, basal control; WE, group that received whey protein in association with neuromuscular electrical stimulation (NMES) in the femoral quadriceps; ES, group that received only NMES in the femoral quadriceps; VL, vastus lateralis muscle; RF, rectus femoris muscle.
Body mass distribution (%) of the injured and healthy limbs during the bipodal mini squat with eyes open (EO) and closed (EC) among the different groups of the study in the pre- and postoperative evaluations.
| Variable | Groups | PRE | POST | ANOVA p value | f2 | ||
|---|---|---|---|---|---|---|---|
| Evaluation | Group | Evaluation*Group | |||||
| IL-EO | BC | 54.57 ± 6.90* | 36.83 ± 11.62 | < 0.001 | 0.178 | 0.533 | 0.610 |
| WE | 45.60 ± 5.22 | 34.32 ± 8.77 | |||||
| ES | 46.34 ± 5.68 | 34.45 ± 10.92 | |||||
| HL-EO | BC | 45.53 ± 6.90* | 63.17 ± 11.62 | < 0.001 | 0.173 | 0.499 | 0.603 |
| WE | 54.92 ± 6.05 | 65.67 ± 8.77 | |||||
| ES | 53.65 ± 5.68 | 65.54 ± 10.92 | |||||
| ANT-EO | BC | 46.96 ± 8.91 | 44.09 ± 12.64 | 0.334 | 0.002 | 0.781 | 0.049 |
| WE | 61.60 ± 4.68† | 58.37 ± 6.20† | |||||
| ES | 52.65 ± 8.64 | 52.68 ± 6.44 | |||||
| POS-EO | BC | 53.34 ± 8.91 | 55.91 ± 12.64 | 0.353 | 0.002 | 0.788 | 0.045 |
| WE | 38.40 ± 4.68† | 41.62 ± 6.20† | |||||
| ES | 47.34 ± 6.50 | 47.31 ± 6.44 | |||||
| IL-EC | BC | 53.62 ± 7.00* | 37.20 ± 11.54 | <0.001 | 0.312 | 0.653 | 0.594 |
| WE | 48.00 ± 7.80 | 35.25 ± 9.35 | |||||
| ES | 45.31 ± 6.50 | 34.68 ± 9.95 | |||||
| HL-EC | BC | 46.38 ± 7.00* | 62.80 ± 11.54 | < 0.001 | 0.694 | 0.677 | 0.690 |
| WE | 52.00 ± 7.80 | 64.75 ± 9.35 | |||||
| ES | 54.68 ± 6.50 | 65.60 ± 10.06 | |||||
| ANT-EC | BC | 50.25 ± 9.82 | 45.48 ± 11.42 | 0.224 | 0.023 | 0.787 | 0.077 |
| WE | 60.07 ± 6.06† | 58.15 ± 7.62† | |||||
| ES | 54.51 ± 9.28 | 53.20 ± 7.43 | |||||
| POS-EC | BC | 49.75 ± 9.82 | 54.52 ± 11.42 | 0.135 | 0.015 | 0.789 | 0.114 |
| WE | 39.25 ± 5.45† | 41.85 ± 7.56† | |||||
| ES | 45.58 ± 9.28 | 46.80 ± 7.43 | |||||
Abbreviations: f2, effect size; BC, basal control group, WE, whey protein and neuromuscular electrical stimulation (NMES) group. ES, NMES group. IL; mass on the injured limb; HL, mass on the healthy limb; ANT, mass in the anterior region; POS, mass in the posterior region;
* versus pre-evaluation, differ significantly based on the Bonferroni test (p < 0.05).
† significant difference in relation to the BC group based on the Bonferroni test (p < 0.05).